These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25921139)
1. Aberrant expression of pim-3 promotes proliferation and migration of ovarian cancer cells. Zhuang H; Zhao MY; Hei KW; Yang BC; Sun L; Du X; Li YM Asian Pac J Cancer Prev; 2015; 16(8):3325-31. PubMed ID: 25921139 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer. Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918 [TBL] [Abstract][Full Text] [Related]
3. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915 [TBL] [Abstract][Full Text] [Related]
4. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway. Wang J; Cai J; Han F; Yang C; Tong Q; Cao T; Wu L; Wang Z Int J Gynecol Cancer; 2011 Aug; 21(6):981-7. PubMed ID: 21738044 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627 [TBL] [Abstract][Full Text] [Related]
6. [Expression of mesothelin mRNA and protein in ovarian carcinomas]. Bi SN; Dai SZ; Yao Q; Che YC; Wang N Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634 [TBL] [Abstract][Full Text] [Related]
7. P73 gene expression in ovarian cancer tissues and cell lines. Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237 [TBL] [Abstract][Full Text] [Related]
8. Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin. Komiyama S; Kurahashi T; Ishikawa M; Tanaka K; Komiyama M; Mikami M; Udagawa Y Oncol Rep; 2011 Apr; 25(4):1131-8. PubMed ID: 21249319 [TBL] [Abstract][Full Text] [Related]
9. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance. Zhang W; Ling D; Tan J; Zhang J; Li L Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-181 Functions as an Antioncogene and Mediates NF-κB Pathway by Targeting RTKN2 in Ovarian Cancers. Lin Z; Li D; Cheng W; Wu J; Wang K; Hu Y Reprod Sci; 2019 Aug; 26(8):1071-1081. PubMed ID: 30309296 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382 [TBL] [Abstract][Full Text] [Related]
12. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334 [TBL] [Abstract][Full Text] [Related]
13. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008 [TBL] [Abstract][Full Text] [Related]
14. Notch1 expression correlates with tumor differentiation status in ovarian carcinoma. Wang M; Wang J; Wang L; Wu L; Xin X Med Oncol; 2010 Dec; 27(4):1329-35. PubMed ID: 20012562 [TBL] [Abstract][Full Text] [Related]
15. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910 [TBL] [Abstract][Full Text] [Related]
16. [Expression of EVEC in ovarian carcinoma and its biological significance]. Wang Q; Li XG; Zhang Y; Cao LQ; Deng ZH; Chen Y Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):676-80. PubMed ID: 21122382 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene. Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060 [TBL] [Abstract][Full Text] [Related]
18. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail. Ding JX; Feng YJ; Yao LQ; Yu M; Jin HY; Yin LH Gynecol Oncol; 2006 Nov; 103(2):623-30. PubMed ID: 16806441 [TBL] [Abstract][Full Text] [Related]
19. Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer. Nakazato T; Kanuma T; Tamura T; Faried LS; Aoki H; Minegishi T Int J Gynecol Cancer; 2007; 17(2):426-32. PubMed ID: 17309563 [TBL] [Abstract][Full Text] [Related]
20. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells. Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]